Search

Your search keyword '"Antigen-Presenting Cells"' showing total 18,076 results

Search Constraints

Start Over You searched for: Descriptor "Antigen-Presenting Cells" Remove constraint Descriptor: "Antigen-Presenting Cells"
18,076 results on '"Antigen-Presenting Cells"'

Search Results

1. Unveiling signaling pathways inducing MHC class II expression in neutrophils.

2. Mannose and Lactobionic Acid in Nasal Vaccination: Enhancing Antigen Delivery via C-Type Lectin Receptors.

3. A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes.

4. Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization

5. Cancer Cell Membrane Nanodiscs for Antitumor Vaccination.

6. A Non‐Coding Oligonucleotide Recruits Cutaneous CD11b+ Cells that Inhibit Thelper Responses and Promote Tregs.

7. Effects of artemisinin and cisplatin on the malignant progression of oral leukoplakia. In vitro and in vivo study.

8. Evaluation of the immunotoxicity potential of nanomaterials using THP-1 cells.

9. Variability of Vaccine Responsiveness in Young Children.

10. Enhancing autophagy in CD11c+ antigen-presenting cells as a therapeutic strategy for acute respiratory distress syndrome

11. Unveiling signaling pathways inducing MHC class II expression in neutrophils

12. Cell‐Sized Lipid Vesicles as Artificial Antigen‐Presenting Cells for Antigen‐Specific T Cell Activation

13. Flavonoids, nobiletin, heptamethoxyflavone, and genistein enhance antigen-presenting cell function in vitro

14. Next-generation pathology detection of T cell-antigen-presenting cell immune synapses in human liver allografts.

15. Group 2 innate lymphoid cells are key in lipid transfer protein allergy pathogenesis.

16. Stem-like CD8 T cells in stage I lung adenocarcinoma as a prognostic biomarker: A preliminary study.

17. 真菌毒素对树突状细胞免疫应答的影响.

18. Enhancement of SARS-CoV-2 mRNA Vaccine Efficacy through the Application of TMSB10 UTR for Superior Antigen Presentation and Immune Activation.

19. Eicosanoid-Regulated Myeloid ENaC and Isolevuglandin Formation in Human Salt-Sensitive Hypertension.

20. A Non‐Coding Oligonucleotide Recruits Cutaneous CD11b+ Cells that Inhibit Thelper Responses and Promote Tregs

21. Strategies and delivery systems for cell-based therapy in autoimmunity

22. A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation

23. Mannose and Lactobionic Acid in Nasal Vaccination: Enhancing Antigen Delivery via C-Type Lectin Receptors

24. T cells use distinct topographical and membrane receptor scanning strategies that individually coalesce during receptor recognition

25. How Neutrophils Shape the Immune Response: Reassessing Their Multifaceted Role in Health and Disease.

26. Cholesterol Metabolism in Antigen-Presenting Cells and HIV-1 Trans-Infection of CD4 + T Cells.

27. Celiac disease: mechanisms and emerging therapeutics.

28. Group 2 innate lymphoid cells are key in lipid transfer protein allergy pathogenesis

29. Expanded specific T cells to hypomutated regions of the SARS-CoV-2 using mRNA electroporated antigen-presenting cells

30. A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes

34. Role of B Cells in Responses to Checkpoint Blockade Immunotherapy and Overall Survival of Cancer Patients

35. Lentinula Edodes Mycelia extract regulates the function of antigen-presenting cells to activate immune cells and prevent tumor-induced deterioration of immune function

36. Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus

37. Sialic acid–modified der p 2 allergen exerts immunomodulatory effects on human PBMCs

38. Proteomic analyses of smearpositive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism.

39. Surface immunogenic protein from Streptococcus agalactiae and Fissurella latimarginata hemocyanin are TLR4 ligands and activate MyD88- and TRIF dependent signaling pathways.

40. Comprehensive single-cell analysis reveals novel anergic antigen-presenting cell subtypes in human sepsis.

41. Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop

42. Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis.

43. Features of the Immune Response in COVID-19

44. CaCO3 powder-mediated biomineralization of antigen nanosponges synergize with PD-1 blockade to potentiate anti-tumor immunity

45. Studying the effect of double-stranded RNA upon activity of mouse splenocytes using flow cytometry

46. Enhancement of SARS-CoV-2 mRNA Vaccine Efficacy through the Application of TMSB10 UTR for Superior Antigen Presentation and Immune Activation

47. Proteomic analyses of smear-positive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism

48. Surface immunogenic protein from Streptococcus agalactiae and Fissurella latimarginata hemocyanin are TLR4 ligands and activate MyD88- and TRIF dependent signaling pathways

49. Lentinula Edodes Mycelia extract regulates the function of antigen-presenting cells to activate immune cells and prevent tumor-induced deterioration of immune function.

50. Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus.

Catalog

Books, media, physical & digital resources